aboutcareers research about contact

December 11, 2013

Certerra has successfully completed Phase I and was awarded Phase II of the SBIR grant “Improving animal-to-human predictability in clinical trials of mental disorder” to continue to build up the animal-to-human PharmacomapTM database, including dose curve response for all 61 mental health medications.

January 3, 2013

Certerra has been awarded a Fast-track Small Business Innovation Research (SBIR) grant of $ 2.1 million from the National Institute of Mental Health. This grant, titled “Improving animal-to-human predictability in clinical trials of mental disorder”, will allow Certerra to build a proprietary PharmacomapTM database of 61 mental health medications, which will be offered to our customers for predictive comparisons of new drug candidates in preclinical screening.

 
homeImage
 
contact